内在凝血途径的接触激活——抗血栓形成研究的新靶点
被引量:5
Intrinsic Clotting Pathway Activation Contact-Anti Thrombosis Research new Targets
摘要
内在凝血途径接触激活的启动因子是凝血因子XII(FXII),激活的FXIIa催化底物是FXI。但由于FXII缺陷并无出血倾向,FXI缺陷的出血倾向远较FⅧ与FIX缺陷为低。因此,长期以来对于内在途径接触环节的生物医学意义存在疑问。近十余年来,由于分子生物学技术和其它先进手段的广泛应用,对此研究有了突破性进展[1-6]。
出处
《血栓与止血学》
2015年第1期57-64,共8页
Chinese Journal of Thrombosis and Hemostasis
参考文献96
-
1B J? ? ? RKQVIST J, NICKEL KF, STAVROU E, et al. In vivo acti- vation and functions of the protease factor XII [ J ]. Thromb Haemost, 2014,112(5) :868-875. 被引量:1
-
2GEDDINGS JE, MACKMAN N. New players in haemostasis and thrombosis [ J ]. Thromb Haemost. 2014 ; 111 (4) :570- 574. 被引量:1
-
3贺石林.凝血因子Ⅻ的研究进展[J].诊断学理论与实践,2013,12(3):367-371. 被引量:5
-
4CHEN Z, SEIFFERT D, HAWES B. Inhibition of Factor XI activity as a promising antithromhotic strategy ] ]. Drug Discov Today. 2014 ; 19 (9) :1435-1439. 被引量:1
-
5MORRISSEY JH. Targeting factor XI to prevent thrombosis[ J]. Arte- rioscier Thromb Vasc Biol. 2013 ;33 (7) : 1454-1455. 被引量:1
-
6HE R, CHEN D, HE S. Factor XI: hemostasis, thrombosis, and an- tithrombosis[ J]. Thronlb Res. 2012 ; 129(5 ) :541-550. 被引量:1
-
7GRUBER A. The role of the contact pathway in thrombus propagation [ J ]. Thromb Res. 2014 ; 133 ( Suppl 1 ) : $45- $47. 被引量:1
-
8KENNE E, RENN6 T. Factor XII:a drug target for safe interference with thrombosis and inflammation [ J]. Drug Discov Today. 2014;19 (9) :1459-1464. 被引量:1
-
9WOODRUFF RS, SULLENGER B, BECKER RC. The many faces of the contact pathway and their role in thrombosis [ J ]. J Thromb Throm- bolysis. 2011 ;32( 1 ) :9-20. 被引量:1
-
10L??? WENBERG EC, MEIJERS JC, MON1A BP, et al. Coagula- tion factor XI as a novel target for antithrombotie treatment [ J ]. J Thromb Haemost. 2010 ;8 ( 11 ) :2349-2357. 被引量:1
二级参考文献33
-
1Cool DE, MacGillivray RT. Characterization of thehuman blood coagulation factor M gene. Intron/exongene organization and analysis of the 5 "-flanking region[J]. J Biol Chem,1987,262(28):13662-13673. 被引量:1
-
2Stavrou E,Schmaier AH. Factor XH : what does itcontribute to our understanding of the physiology andpathophysiology of hemostasis & thrombosis [J]. ThrombRes,2010,125(3):210-215. 被引量:1
-
3Farsetti A, Moretti F, Narducci M, et al. Orphanreceptor hepatocyte nuclear factor-4 antagonizes estrogenreceptor alpha-mediated induction of human coagulationfactor XH gene [J]. Endocrinology, 1998,139 (11):4581 -4589. 被引量:1
-
4Inoue Y, Peters LL, Yim SH, et al. Role of hepatocytenuclear factor 4alpha in control of blood coagulationfactor gene expression [J]. J Mol Med (Berl),2006,84 (4):334-344. 被引量:1
-
5Jablonska E, Mark art P, Zakrzewicz D, et al.Transforming growth factor-pi induces expression ofhuman coagulation factor XD via Smad3 and JNKsignaling pathways in human lung fibroblastsfj]. J BiolChem,2010,285(15):11638-11651. 被引量:1
-
6Citarella F, Felici A, Brouwer M, et al. Interleukin-6downregulates factor XE production by human hepatomacell line (HepG2)[J]. Blood,1997,90(4):1501-1507. 被引量:1
-
7Schmaier AH, Larusch G. Factor XD: new life for an oldprotein[J]. Thromb Haemost,2010,104(5):915-918. 被引量:1
-
8LaRusch GA, Mahdi F, Shariat-Madar Z, et al. Factor XEstimulates ERK1/2 and Akt through uPAR, integrins,and the EGFR to initiate angiogenesis[J]. Blood,2010,l 15(24):5111-5120. 被引量:1
-
9Smith SA, Mutch NJ,Baskar D, et al. Polyphosphatemodulates blood coagulation and fibrinolysis[J]. Proc NatlAcad Sci U S A,2006,103(4):903-908. 被引量:1
-
10Caen J, Wu Q. Hageman factor, platelets andpolyphosphates: early history and recent connection [J].J Thromb Haemost,2010,8(8): 1670-1674. 被引量:1
共引文献4
-
1李姗姗,沈晨芳,舒旷怡,柳洁,王晓欧,李帆帆,杨啸,章赵华,陈碧,江明华.两个遗传性凝血因子Ⅻ缺陷症家系的表型及基因分析[J].中华医学遗传学杂志,2018,35(6):800-803. 被引量:7
-
2沈伟,杨炼,于霞,刘成桂.单独活化部分凝血活酶时间延长患儿的凝血因子缺乏及其抑制物存在情况的临床研究[J].国际输血及血液学杂志,2017,40(5):393-396. 被引量:4
-
3李姗姗,柳洁,沈晨芳,舒旷怡,王晓欧,李帆帆,杨啸,杨威,王锦乐,江明华.一个遗传性凝血因子Ⅻ缺乏症家系的临床表型及基因分析[J].中华血液学杂志,2018,39(8):679-681. 被引量:1
-
4谢海啸,张海月,许梦洁,邹安庆,金艳慧,杨丽红,潘景业,王明山.一个复合杂合变异导致的遗传性凝血因子Ⅻ缺陷症家系分析[J].中华医学遗传学杂志,2020,37(5):519-522. 被引量:9
同被引文献38
-
1Smid M, Dielis AW, Winkens M, et al. Thrombin generation in patients with a first acute myocardial infarction [J]. J Thromb Haenost, 2011,9(3) :450 -456. 被引量:1
-
2Gabriel S, James SK, Dan A, et al. The task force on the management of ST - segment elevation acute myocardial infarction of the European Society of Cardiology ( ESC ). ESC Guidelines for the management of acute myocardial infarction in patients presen- ting with ST - segment elevation [ J ]. Eur Heart J, 2012, 33 (20) : 2569 -2619. 被引量:1
-
3Ardissino D, Merlini PA, Bauer KA, et al. Thrombogenic poten- tial of human coronary atherosclerotic plaques[J]. Blood, 2001, 98 (9) :2726 - 2729. 被引量:1
-
4Owens AP 3 rd, Mackman N. Tissue factor and thrombosis:The clot starts here[ J]. Thromb Haemost, 2010, 104(3) :432 -439. 被引量:1
-
5Demetz G, seitzl, stein A, et al. Tissue factor - factor VIIa com- plex induces cytokine expression coronary artery smooth muscle cells[ J]. Atherosclerosis, 2010, 212(2):466-471. 被引量:1
-
6Steppich BA, Braun SL, Stein A, et al. Plasma TF activity predicts cardiovascular mortality in patients with acute myocardial infarction [J]. Thromb J, 2009, 7(2):7-11. 被引量:1
-
7Lwaleed BA, Bass PS. Tissue factor pathway inhibirot : Structure, biology and involvement in disease[ J]. J Phatol, 2006, 208 ( 3 ) : 327 - 339. 被引量:1
-
8Morange PE, Blankenberg S, Alessi MC, et al. Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovas cular death in patients with coronary artery disease:the Athero Gene Study[J]. J Thromb Haemost, 2007, 5(3) :475 -482. 被引量:1
-
9Kemona - chetnik I, Bodzenta - Lukaszyk A, Kucharewicz I, et al. Tissue factor and tissue factor pathway inhibitor during specific bronchial challenge in allergic asthma patients [ J ]. Przegl Lek, 2005, 62(2) :98 - 101. 被引量:1
-
10Gruber A. The role of the conmtact pathway in thrombus propagation [ J ]. Thromb Res, 2014, 133(suppl 1 ) :S45 - S47. 被引量:1
引证文献5
-
1王蕊,马瑾,陈德,吴波,王渊铭,黄睛,王萍,戴月,唐静辉.老年缺血性心脏病患者组织因子组织因子途径抑制物比值的变化及意义[J].中国急救医学,2016,36(2):142-145. 被引量:3
-
2张银龙,崔玉凤,李树锋.中性粒细胞胞外诱捕网水平与全髋关节置换术后下肢深静脉血栓形成相关性[J].齐鲁医学杂志,2017,32(3):311-314. 被引量:3
-
3刘惠娜,曹旺,邹芳,邓常清.药根碱抗大鼠动脉血栓和静脉血栓形成作用的研究[J].中药药理与临床,2020,36(2):126-132. 被引量:3
-
4孟燕,马强,潘龙飞,秦皓,张波.凝血因子Ⅺ和凝血因子Ⅻ与急性肺栓塞患者疾病严重程度的关系及其作用机制研究[J].实用心脑肺血管病杂志,2020,28(10):9-13. 被引量:8
-
5刘惠娜,李艳玲,曹旺,邓常清.药根碱靶向凝血因子Ⅻ发挥抗凝血作用的体外研究[J].湖南中医药大学学报,2021,41(1):27-33. 被引量:1
二级引证文献18
-
1姚楷南,李航,李泽丽,周继红.黄连活性成分药根碱干预T790M突变EGFR-TKIs耐药非小细胞肺癌的机制研究——基于网络药理学及实验验证[J].世界科学技术-中医药现代化,2022,24(9):3491-3503. 被引量:3
-
2邓日强,侯红梅,谢俊玲.血浆组织因子途径抑制物水平与肺血栓栓塞症的关系分析[J].河北医学,2017,23(5):826-828. 被引量:1
-
3孙丹丹,梁秀琴,闫清秀.髋关节置换术患者下肢深静脉血栓发生的危险因素[J].全科口腔医学电子杂志,2020,7(1):24-25. 被引量:1
-
4刘惠娜,李艳玲,曹旺,邓常清.药根碱靶向凝血因子Ⅻ发挥抗凝血作用的体外研究[J].湖南中医药大学学报,2021,41(1):27-33. 被引量:1
-
5殷宁,宋莉,陆迎爱,牛利利,杨秋荣,宫艳艳,庄娜.急性心肌梗死患者直接PCI后无复流的研究进展[J].医学综述,2021,27(4):743-747. 被引量:15
-
6刘媛,刘春芳,张杰.凝血因子Ⅷ联合D-二聚体评估肺血栓栓塞症的预后价值[J].中国医药指南,2021,19(7):98-99. 被引量:1
-
7赵玉升,李伟洋,曹天佑,赵琰,屈会化.中药炭药止血物质基础概述[J].中医药导报,2021,27(8):56-60. 被引量:12
-
8田孟茶,陈雅斌,吴聪莲.凝血因子F Ⅻ 46C→T基因多态性与急性心肌梗死研究[J].中国卫生标准管理,2021,12(17):32-34.
-
9侯彦杰,李小玲,刘园园,马亮英.活血灵方对大鼠下肢深静脉血栓形成及Notch2/Hes-1表达的影响[J].中医药信息,2021,38(10):23-28. 被引量:4
-
10龚姝姝.多层CT肺血管成像对急性肺栓塞严重程度的评估准确性分析[J].影像研究与医学应用,2022,6(5):50-52. 被引量:4
-
1沈卫章,王鸿利.凝血因子Ⅻ与血栓形成[J].国际输血及血液学杂志,2006,29(1):17-20. 被引量:2
-
2王学锋,戴菁,王明山,丁秋兰,王鸿利.两个遗传性凝血因子Ⅻ缺陷症家系FⅫ基因突变分析[J].诊断学理论与实践,2005,4(6):447-450. 被引量:13
-
3徐姗,姚咏明,盛志勇.树突细胞与T淋巴细胞相互作用及其免疫调节效应[J].解放军医学杂志,2006,31(9):919-921. 被引量:2
-
4李辉,马丹丹,傅羽.组织因子途径抑制物在动脉粥样硬化中的作用[J].中国动脉硬化杂志,2016,24(3):306-310. 被引量:6
-
5贺石林,熊石龙,贺蓉,何晓凡,刘发益,汉建忠,李俊成.FⅫa受抑稀释凝血活酶试验反映凝血过程的研究[J].中华血液学杂志,2000,21(3):118-121. 被引量:14
-
6谢海啸,王莹宇,周武,王秀秀,王明山.凝血因子Ⅻ缺陷症导致再发体外受精和胚胎移植失败原因2例分析[J].温州医学院学报,2014,44(4):286-289. 被引量:3
-
7刁戈,马莉,林方昭,周敏,孙盼,李长清,肖小璞.1例凝血因子Ⅺ缺乏症的基因突变研究[J].中国输血杂志,2012,25(2):142-144. 被引量:5
-
8霍红,张从昕,赵东宝,戴生明.白介素-18增强T淋巴细胞直接接触激活的单核细胞分泌细胞因子的功能[J].第二军医大学学报,2009,30(2):157-161. 被引量:1
-
9魏欣,王威威,崔国辉,赵明,王超,彭师奇.以血栓和骨质疏松为靶的伪肽研究进展[J].首都医科大学学报,2005,26(1):33-36.
-
10李峰,邓冰湘.多媒体技术在生理学教学中的应用[J].湖南中医药大学学报,2012,32(2):62-63. 被引量:6